All Pharma News
Relma-Cel Data In Lupus Patients Presented At Eular 2024 Congress

Relma-Cel Data In Lupus Patients Presented At Eular 2024 Congress
PR NEWSWIRE
30 May 2024
Share Share
JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel

JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel
PR NEWSWIRE
10 Apr 2023
Share Share
JW Announces Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients

JW Announces Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients
PR NEWSWIRE
29 Mar 2023
Share Share
JW Therapeutics Announces Initiation of Study of Carteyva for Large B-Cell Lymphoma

JW Therapeutics Announces Initiation of Study of Carteyva for Large B-Cell Lymphoma
PR NEWSWIRE
08 Mar 2023
Share Share
JW Therapeutics Announces Initiation of Clinical Study of JWATM214

JW Therapeutics Announces Initiation of Clinical Study of JWATM214
PR NEWSWIRE
28 Feb 2023
Share Share
JW Therapeutics Presents Latest Clinical Data on Carteyva at ASH

JW Therapeutics Presents Latest Clinical Data on Carteyva at ASH
PRNEWSWIRE
12 Dec 2022
Share Share
2seventy and JW Therapeutics partner to develop immunotherapies

2seventy and JW Therapeutics partner to develop immunotherapies
PHARMACEUTICAL-TECHNOLOGY
28 Oct 2022
Share Share
2seventy bio and JW Therapeutics Announce Strategic Partnership

2seventy bio and JW Therapeutics Announce Strategic Partnership
BUSINESSWIRE
27 Oct 2022
Share Share
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection
PRNEWSWIRE
10 Oct 2022
Share Share
JW Therapeutics Initiates Study of JWATM204 in Advanced HCC

JW Therapeutics Initiates Study of JWATM204 in Advanced HCC
ASIAONE
04 Jul 2022
Share Share